Research Appraisalother

Artificial intelligence in atopic dermatitis: Current applications and future perspectives.

Chinese medical journalChen, Yujia, Li, Jingyi5 May 2026DOI

Clinical Snapshot

20CEBM
Evidence: Weakother

PICO Framework

P — PopulationPatients with atopic dermatitis
I — InterventionArtificial intelligence applications (diagnostic tools, severity scoring, outcome prediction)
C — ComparatorTraditional clinical assessment methods
O — OutcomesDiagnostic accuracy, severity assessment, treatment outcomes, quality of care

Bottom Line

This narrative review explores artificial intelligence applications in atopic dermatitis management, covering diagnostic tools, severity assessment, and treatment personalisation. However, the review lacks systematic methodology, clear search strategies, and quality assessment of included studies, significantly limiting its evidence value. While the topic is clinically relevant given the burden of atopic dermatitis, the absence of quantitative synthesis or critical appraisal means clinicians cannot reliably assess the actual effectiveness or readiness of these AI technologies for practice implementation. The review reads more as an opinion piece than evidence-based guidance. Australian clinicians should await more rigorous systematic reviews and local validation studies before considering AI integration into dermatology practice, particularly given current TGA regulatory requirements for medical devices.

Evidence: Weak

Key Findings

  • Effect Size: Not provided

  • Primary Outcome: Not specified - narrative overview of AI applications

  • Nnt Or Sensitivity: Not provided

  • Confidence Interval: Not provided

Clinical Application

Limited by current AI technology availability and validation in clinical practice Relevance to Australian dermatology practice unclear without TGA-approved AI tools or PBS considerations for digital health technologies Patients with atopic dermatitis in various healthcare settings

Abstract

Atopic dermatitis (AD) is a prevalent and burdensome chronic skin disease, with profound effects on patient quality of life. Advancing its diagnosis and management remains a pressing clinical need. Artificial intelligence holds growing promise in addressing this challenge. This review outlines the current landscape of AD and explores the expanding role of AI in its care-from improving diagnostic accuracy and objective severity scoring to predicting therapeutic outcomes and personalizing treatment strategies. While these technologies are poised to transform dermatology practice, their successful integration will depend on overcoming technical and practical barriers through collaborative, interdisciplinary efforts. Further research and thoughtful implementation are essential to translate AI's potential into better, more precise patient care.

References

  1. 1.Chen, Y., & Li, J. (2026). Artificial intelligence in atopic dermatitis: Current applications and future perspectives. Chinese Medical Journal. https://doi.org/10.1097/CM9.0000000000004020
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service